Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
6.29
-0.14 (-2.18%)
At close: Apr 28, 2026, 4:00 PM EDT
6.24
-0.05 (-0.79%)
After-hours: Apr 28, 2026, 6:31 PM EDT
Aligos Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -24.19 | -131.21 | -87.68 | -96.05 | -128.33 | |
| Depreciation & Amortization | 0.93 | 1.03 | 3.07 | 3.68 | 3.78 | |
| Loss (Gain) From Sale of Assets | - | - | 0.02 | - | - | |
| Asset Writedown & Restructuring Costs | - | - | 0.72 | - | - | |
| Loss (Gain) From Sale of Investments | -2.19 | -1.78 | -0.42 | -0.16 | 0.09 | |
| Stock-Based Compensation | 5.04 | 8.45 | 12.65 | 14.69 | 13.46 | |
| Other Operating Activities | -58.31 | 47.73 | 2.17 | - | - | |
| Change in Accounts Payable | 1.41 | 0.05 | -2.22 | 1.72 | -0.31 | |
| Change in Unearned Revenue | -0.15 | -1.16 | -8.14 | 2.5 | -4.36 | |
| Change in Other Net Operating Assets | -5.05 | -3.85 | 0.83 | -5.78 | 0.02 | |
| Operating Cash Flow | -82.5 | -80.74 | -79 | -79.39 | -115.66 | |
| Capital Expenditures | -0.44 | -0.13 | -0.02 | -0.94 | -0.89 | |
| Investment in Securities | -37.39 | -18.15 | 45 | -25.35 | 3.91 | |
| Investing Cash Flow | -37.83 | -18.28 | 44.98 | -26.29 | 3.02 | |
| Long-Term Debt Repaid | -0.01 | -0.08 | -0.1 | -0.06 | -0.08 | |
| Total Debt Repaid | -0.01 | -0.08 | -0.1 | -0.06 | -0.08 | |
| Net Debt Issued (Repaid) | -0.01 | -0.08 | -0.1 | -0.06 | -0.08 | |
| Issuance of Common Stock | 101.65 | 0.44 | 18.02 | 0.23 | 79.63 | |
| Other Financing Activities | - | - | 70.41 | - | -0.88 | |
| Financing Cash Flow | 101.64 | 0.36 | 88.33 | 0.16 | 78.68 | |
| Net Cash Flow | -18.69 | -98.67 | 54.31 | -105.52 | -33.96 | |
| Free Cash Flow | -82.94 | -80.87 | -79.02 | -80.33 | -116.55 | |
| Free Cash Flow Margin | -3794.15% | -2050.01% | -508.83% | -577.64% | -2673.87% | |
| Free Cash Flow Per Share | -8.39 | -12.91 | -30.82 | -47.04 | -73.11 | |
| Levered Free Cash Flow | -50.04 | -48.58 | -45.91 | -43.65 | -62.76 | |
| Unlevered Free Cash Flow | -50.04 | -48.58 | -45.91 | -43.65 | -62.76 | |
| Change in Working Capital | -3.79 | -4.96 | -9.53 | -1.55 | -4.65 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.